RESIST-TB webinar: Combined use of delamanid and bedaquiline

RESIST-TB will host a webinar about the current evidence and practices for the combined use of delamanid and bedaquiline for the treatment of multidrug-resistant TB (MDR-TB) on 5 April 2018.

For more information about the webinar and how to connect, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By RESIST-TB

Published: March 29, 2018, 10:37 p.m.

Last updated: March 29, 2018, 10:38 p.m.

Print Share